Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with H

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
3498 Q3 2021 HYDROGENATED SOYBEAN LECITHIN INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL 9.58 mg/ml Correction
3498 Q4 2021 HYDROGENATED SOYBEAN PHOSPHATIDYLCHOLINE INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL 9.58 mg/ml Correction
3596 Q3 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) ORAL TABLET, CHEWABLE 20 mg Correction
3596 Q4 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) ORAL TABLET, CHEWABLE 10 mg Correction
3691 Q3 2021 HYPROMELLOSE 2208 (100000 MPA.S) ORAL TABLET, FILM COATED 536.80 mg Correction
3691 Q4 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL TABLET, FILM COATED 10.00 mg Correction
3711 Q3 2021 HYPROMELLOSE 2208 (3 MPA.S) ORAL TABLET, EXTENDED RELEASE 184.25 mg Correction
3711 Q4 2021 HYPROMELLOSE 2208 (3 MPA.S) ORAL TABLET, EXTENDED RELEASE 85.50 mg Correction
3478 Q3 2021 HYDROGENATED COTTONSEED OIL ORAL TABLET 34.00 mg MDE Replacement
3478 Q4 2021 HYDROGENATED COTTONSEED OIL ORAL TABLET 54.4 mg MDE Replacement
3482 Q3 2021 HYDROGENATED COTTONSEED OIL ORAL TABLET, EXTENDED RELEASE 228.00 mg MDE Replacement
3482 Q4 2021 HYDROGENATED COTTONSEED OIL ORAL TABLET, EXTENDED RELEASE 2280 mg MDE Replacement
3493 Q3 2021 HYDROGENATED SOYBEAN OIL ORAL TABLET, EXTENDED RELEASE 48.00 mg MDE Replacement
3493 Q4 2021 HYDROGENATED SOYBEAN OIL ORAL TABLET, EXTENDED RELEASE 96 mg MDE Replacement
3508 Q3 2021 HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) BUCCAL FILM 54.92 mg MDE Replacement
3508 Q4 2021 HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) BUCCAL FILM 54.92 mg MDE Replacement
3509 Q3 2021 HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) BUCCAL FILM, SOLUBLE 39.88 mg MDE Replacement
3509 Q4 2021 HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) BUCCAL FILM, SOLUBLE 160 mg MDE Replacement
3542 Q3 2021 HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) ORAL TABLET, EXTENDED RELEASE 400.00 mg MDE Replacement
3542 Q4 2021 HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) ORAL TABLET, EXTENDED RELEASE 800 mg MDE Replacement
3544 Q3 2021 HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) TOPICAL GEL 1.50 %w/w MDE Replacement
3544 Q4 2021 HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) TOPICAL GEL 25 mg MDE Replacement
3550 Q3 2021 HYDROXYETHYL CELLULOSE (6500 MPA.S AT 2%) ORAL TABLET, EXTENDED RELEASE 150.00 mg MDE Replacement
3550 Q4 2021 HYDROXYETHYL CELLULOSE (6500 MPA.S AT 2%) ORAL TABLET, EXTENDED RELEASE 300 mg MDE Replacement
3584 Q3 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) BUCCAL FILM, SOLUBLE 72.91 mg MDE Replacement
3584 Q4 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) BUCCAL FILM, SOLUBLE 292 mg MDE Replacement
3591 Q3 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) ORAL GRANULE, FOR SUSPENSION 39.00 mg MDE Replacement
3591 Q4 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) ORAL GRANULE, FOR SUSPENSION 193.8 mg MDE Replacement
3639 Q3 2021 HYPROMELLOSE ORAL CAPSULE, DELAYED RELEASE 4.50 mg MDE Replacement
3639 Q4 2021 HYPROMELLOSE ORAL CAPSULE, DELAYED RELEASE 34.85 mg MDE Replacement
3660 Q3 2021 HYPROMELLOSE ORAL TABLET, COATED 35.39 mg MDE Replacement
3660 Q4 2021 HYPROMELLOSE ORAL TABLET, COATED 57.6 mg MDE Replacement
3682 Q3 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL SUSPENSION 50.00 mg/ 5.00 ml MDE Replacement
3682 Q4 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL SUSPENSION 50 mg MDE Replacement
3683 Q3 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL SYRUP 12.50 mg/ 5.00 ml MDE Replacement
3683 Q4 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL SYRUP 100 mg MDE Replacement
3685 Q3 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL TABLET, DELAYED RELEASE 90.00 mg MDE Replacement
3685 Q4 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL TABLET, DELAYED RELEASE 360 mg MDE Replacement
3700 Q3 2021 HYPROMELLOSE 2208 (15000 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 300.00 mg MDE Replacement
3700 Q4 2021 HYPROMELLOSE 2208 (15000 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 400 mg MDE Replacement
3701 Q3 2021 HYPROMELLOSE 2208 (200000 MPA.S) ORAL TABLET, EXTENDED RELEASE 212.00 mg MDE Replacement
3701 Q4 2021 HYPROMELLOSE 2208 (200000 MPA.S) ORAL TABLET, EXTENDED RELEASE 460 mg MDE Replacement
3720 Q3 2021 HYPROMELLOSE 2208 (4000 MPA.S) VAGINAL CREAM 0.30 %w/w MDE Replacement
3720 Q4 2021 HYPROMELLOSE 2208 (4000 MPA.S) VAGINAL CREAM 12 mg MDE Replacement
3739 Q3 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL CAPSULE, EXTENDED RELEASE 54.40 mg MDE Replacement
3739 Q4 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL CAPSULE, EXTENDED RELEASE 70.7 mg MDE Replacement
3744 Q3 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL TABLET, EXTENDED RELEASE 255.85 mg MDE Replacement
3744 Q4 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL TABLET, EXTENDED RELEASE 510 mg MDE Replacement
3746 Q3 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 7.50 mg MDE Replacement
3746 Q4 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 15 mg MDE Replacement
3754 Q3 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL CAPSULE 193.91 mg MDE Replacement
3754 Q4 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL CAPSULE 775.64 mg MDE Replacement
3755 Q3 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL GRANULE 10.40 mg MDE Replacement
3755 Q4 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL GRANULE 21 mg MDE Replacement
3756 Q3 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL GRANULE, FOR SUSPENSION 1.00 mg MDE Replacement
3756 Q4 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL GRANULE, FOR SUSPENSION 1 mg MDE Replacement
3761 Q3 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL TABLET, EXTENDED RELEASE 42.41 mg MDE Replacement
3761 Q4 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL TABLET, EXTENDED RELEASE 53.32 mg MDE Replacement
3768 Q3 2021 HYPROMELLOSE 2910 (4000 MPA.S) NASAL SPRAY, METERED 1.00 mg/ 1.00 ml MDE Replacement
3768 Q4 2021 HYPROMELLOSE 2910 (4000 MPA.S) NASAL SPRAY, METERED 1.096 mg MDE Replacement
3778 Q3 2021 HYPROMELLOSE 2910 (4000 MPA.S) ORAL SYRUP 180.00 mg/ 5.00 ml MDE Replacement
3778 Q4 2021 HYPROMELLOSE 2910 (4000 MPA.S) ORAL SYRUP 360 mg MDE Replacement
3794 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL CAPSULE, EXTENDED RELEASE 670.04 mg MDE Replacement
3794 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL CAPSULE, EXTENDED RELEASE 963.81 mg MDE Replacement
3796 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL GRANULE, FOR SUSPENSION 24.08 mg MDE Replacement
3796 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL GRANULE, FOR SUSPENSION 48.16 mg MDE Replacement
3797 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL POWDER, FOR SUSPENSION 75.00 mg/ 5.00 ml MDE Replacement
3797 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL POWDER, FOR SUSPENSION 450 mg MDE Replacement
3798 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL SUSPENSION 325.00 mg/ 5.00 ml MDE Replacement
3798 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL SUSPENSION 975 mg MDE Replacement
3800 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL SYRUP 5.00 mg/ 1.00 ml MDE Replacement
3800 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL SYRUP 200 mg MDE Replacement
3801 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET 444.40 mg MDE Replacement
3801 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET 1200 mg MDE Replacement
3807 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 54.00 mg MDE Replacement
3807 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 106.6 mg MDE Replacement
3808 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET, FOR SUSPENSION 19.00 mg MDE Replacement
3808 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET, FOR SUSPENSION 76 mg MDE Replacement
Q3 2021 HYPROMELLOSE 2910 (6 MPA.S) ORAL CAPSULE, DELAYED RELEASE 78.00 mg MDE Replacement
Q4 2021 HYPROMELLOSE 2910 (6 MPA.S) ORAL CAPSULE, DELAYED RELEASE 223 mg MDE Replacement
3832 Q3 2021 HYPROMELLOSE ACETATE SUCCINATE ORAL CAPSULE, EXTENDED RELEASE 66.78 mg MDE Replacement
3832 Q4 2021 HYPROMELLOSE ACETATE SUCCINATE ORAL CAPSULE, EXTENDED RELEASE 66.78 mg MDE Replacement
3487 Q4 2021 HYDROGENATED SOYBEAN LECITHIN INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL 0.96 %w/v Deletion
3496 Q4 2021 HYDROLYZED SOY PROTEIN (ENZYMATIC; 2000 MW) INTRAVENOUS INJECTABLE, LIPOSOMAL 0.96 %w/v Deletion
3641 Q4 2021 HYPROMELLOSE NASAL SPRAY, METERED 1.00 mg/ 1.00 ml Deletion
3678 Q4 2021 HYPROMELLOSE 2208 (100 MPA.S) BUCCAL TABLET, DELAYED RELEASE 17.25 mg Deletion
3684 Q4 2021 HYPROMELLOSE 2208 (100000 MPA.S) ORAL TABLET, FILM COATED 536.80 mg Deletion
3833 Q4 2021 HYPROMELLOSE PHTHALATE ORAL CAPSULE 48.10 mg Deletion
3851 Q4 2021 HYPROMELLOSE PHTHALATE ORAL TABLET, FILM COATED 23.10 mg Deletion
3861 Q4 2021 HYPROMELLOSE PHTHALATE ORAL TABLET, DELAYED RELEASE 16.42 mg Deletion

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English